Description: Cardiac Insight, Inc. is a privately held medical device company based in Seattle, WA. Cardiac Insight is developing advanced, body worn ECG sensing technology aimed at the early diagnosis of atrial fibrillation (AF) and other conditions. Earlier last year, the company announced a strategic collaboration with Welch Allyn, now part of the Hill-Rom family of companies, for the distribution rights of certain products and technologies offered by Cardiac Insight. In September, 2015, Cardiac Insight completed the acquisition of Cardea Associates, Inc., a company dedicated to cardiovascular research and product innovation. CardeaScreen™, developed and produced by Cardea, is a proprietary, handheld 12-lead ECG device and software that provides a major breakthrough to improve the reliability of the electrocardiogram (ECG) for the identification of cardiovascular issues associated with sudden cardiac arrest (SCA) in young athletes.
Business Profile
